About Gastroenterologie, s. r. o.
"Gastroenterologie s.r.o. byla založena roku 2006 a od počátku existence zaměřila své spektrum působnosti na územní pokrytí medicínské činnosti v oblasti onemocnění trávicího ústrojí. Jejím cílem je dosáhnutí co nejdokonalejší diferenciální diagnostiky s co možná největším počtem spokojených klientů. Pracovní tým našeho zařízení se skládá z vysoce kvalifikovaných pracovníků s dlouholetými klinickými zkušenostmi v oblasti gastroenterologie a hepatologie. Každoročně naše ambulance ošetří více jak 5000 pacientů a provede 1100 endoskopických vyšetření (gastroskopie, kolonoskopie). MZ České republiky delegovalo naší gastroenterologii mezi referenční pracoviště podílející se na uskutečňování Programu prevence kolorektálního karcinomu."
Clinical Trials at Gastroenterologie, s. r. o.
During the past decade, Gastroenterologie, s. r. o. conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 2 clinical trials were completed, i.e. on
average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Gastroenterologie, s. r. o.
According to Clinical.Site data, the most researched conditions in "Gastroenterologie, s. r. o." are
"Crohn Disease" (2 trials), "Chronic Idiopathic Constipation" (1 trials), "Colitis, Ulcerative" (1 trials), "Constipation" (1 trials) and "Faecal Incontinence" (1 trials). Many other conditions were trialed in "Gastroenterologie, s. r. o." in a lesser frequency.
Clinical Trials Intervention Types at Gastroenterologie, s. r. o.
Most popular intervention types in "Gastroenterologie, s. r. o." are "Drug" (7 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (5 trials), "Etrolizumab" (2 trials), "1R, 2S-methoxamine hydrochloride" (1 trials), "Elobixibat 10 mg" (1 trials) and "Elobixibat 5 mg" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Gastroenterologie, s. r. o.
The vast majority of trials in "Gastroenterologie, s. r. o." are
7 trials for "All" genders.
Clinical Trials Status at Gastroenterologie, s. r. o.
Currently, there are NaN active trials in "Gastroenterologie, s. r. o.".
undefined are not yet recruiting,
1 are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 3 completed trials in Gastroenterologie, s. r. o.,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Gastroenterologie, s. r. o., 0 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 6 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".
Departments of Gastroenterologie, s. r. o.
Gastroenterologie, s. r. o. has several departments that took part in Clinical trials: "Gastroenterologie s.r.o. Manesova 646" - 2 trials